Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $723.97 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $288.72 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $148.56 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $134.04 | 2 | $0 (2024) |
| Novo Nordisk Inc | $109.18 | 3 | $0 (2024) |
| ABBVIE INC. | $43.47 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $522.05 | 15 | Lilly USA, LLC ($164.20) |
| 2023 | $201.92 | 2 | Lilly USA, LLC ($124.52) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: Obesity | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Diabetes | ||||||
| 06/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $116.66 | General |
| Category: Obesity | ||||||
| 05/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $120.79 | General |
| Category: VACCINES | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: Respiratory | ||||||
| 03/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: VACCINES | ||||||
| 06/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.52 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $77.40 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 114 | 133 | $20,715 | $8,198 |
| 2022 | 3 | 92 | 95 | $14,897 | $6,308 |
| 2021 | 4 | 191 | 195 | $23,022 | $10,597 |
| 2020 | 6 | 188 | 221 | $20,132 | $7,197 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 53 | $9,594 | $3,766 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 38 | $4,728 | $2,034 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $3,897 | $1,349 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,331 | $1,012 | 43.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $165.00 | $37.51 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 37 | $6,928 | $3,001 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 38 | $4,868 | $1,953 | 40.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $3,101 | $1,354 | 43.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 104 | 104 | $16,016 | $7,285 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 55 | $5,854 | $3,102 | 53.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 18 | $882.00 | $148.32 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 18 | $270.00 | $62.64 | 23.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 66 | 66 | $10,164 | $3,467 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 50 | $5,300 | $2,089 | 39.4% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 25 | 25 | $2,400 | $1,347 | 56.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 24 | $1,176 | $186.27 | 15.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 24 | 28 | $420.00 | $96.60 | 23.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 11 | 28 | $672.00 | $11.07 | 1.6% |
About Lora Kinner
Lora Kinner is a Nurse Practitioner healthcare provider based in Mason, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1740767144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lora Kinner has received a total of $723.97 in payments from pharmaceutical and medical device companies, with $522.05 received in 2024. These payments were reported across 17 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($723.97).
As a Medicare-enrolled provider, Kinner has provided services to 585 Medicare beneficiaries, totaling 644 services with total Medicare billing of $32,301. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Mason, OH
- Active Since 07/27/2018
- Last Updated 11/05/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1740767144
Products in Payments
- MOUNJARO (Drug) $165.27
- AIRSUPRA (Drug) $135.15
- SHINGRIX (Biological) $134.04
- ZEPBOUND (Drug) $123.45
- Wegovy (Drug) $77.40
- QULIPTA (Drug) $43.47
- Rybelsus (Drug) $16.57
- Ozempic (Drug) $15.21
- BREZTRI (Drug) $13.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Mason
Mr. Seth Stephenson
Nurse Practitioner — Payments: $33,075
Mrs. Sarah Serrao, Np, NP
Nurse Practitioner — Payments: $9,917
Ms. Michelle Khosla, N.p, N.P
Nurse Practitioner — Payments: $6,116
Maria Weitfle, C.n.p, C.N.P
Nurse Practitioner — Payments: $3,775
Danielle Abney
Nurse Practitioner — Payments: $2,240
Bonnie Rebella, Np, NP
Nurse Practitioner — Payments: $1,654